Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Wright Profemur Hip Settlement Reached Days Before Trial Set To Begin April 8, 2013 Austin Kirk Add Your Comments Just days before trial was scheduled to begin, an agreement has been reached to settle a Wright hip replacement lawsuit filed by a man who alleged that a Profemur hip implant failed after just four years. The settlement was disclosed in a court order (PDF) issued by U.S. District Court Judge Yvonne Gonzalez Rogers on March 20, involving a product liability lawsuit brought by Gregory Tucker against Wright Medical Technology, Inc. Before the agreement was reached, trial was scheduled to begin in the case on April 1, in the U.S. District Court for the Northern District of California. Stay Up-to-Date About hip replacement lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new hip replacement lawsuit updates or developments. "*" indicates required fields Email* SIGN ME UP Δ Learn More Stay Up-to-Date About Hip Replacement Lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new hip replacement lawsuit updates or developments. "*" indicates required fields Email* SIGN ME UP Δ Learn More Tucker filed the hip replacement lawsuit in May 2011, alleging that he experienced problems with a Wright Profemur Hip System that was implanted in his right hip in March 2006. On May 7, 2010, Tucker’s hip implant fractured, resulting in the need for revision surgery to remove the Profemur hip and replace it with another device. The settlement was reported just one day after Judge Rogers issued another order (PDF), denying an attempt by Wright Medical to have the case dismissed. While Judge Rogers granted Wright Medical’s Motion for Summary Judgment as to claims for strict liability based on design defect, manufacturing defect and failure to warn, as well as negligence claims for failure to warn, the case was allowed to proceed under claims for negligence based on design defect. Unlike traditional hip replacement systems, which feature a single femoral component, the Wright Profemur hip features two modular pieces that allow the implant to be adjusted for leg length. However, Tucker alleged that the design was prone to fret, corrode and fatigue around the modular junction as the metal parts rub against each other. A number of other Wright Profemur hip lawsuits have been filed in courts throughout the country by individuals who experienced similar problems, and this trial was going to be closely watched by product liability lawyers involved in the litigation, as it may have gauged how juries would respond to similar evidence and testimony that would be offered throughout other cases. Details of the Wright Profemur hip settlement reached in the Tucker case were not disclosed by the court. In August, Wright Medical filed a report with the Securities and Exchange Commission (SEC) providing updated information about the pending product liability lawsuits over the Profemur modular hip, estimating that their liability may be between $24 million and $39 million for cases brought by individuals in North America who required a revision surgery following the fracture of a long Profemur titanium modular neck, or who may require revision in the future. The company has estimated that they will pay the majority of any settlements for Wright Profemur fractures within the next four years. Tags: California, Hip Replacement System, Metal-on-Metal Hip, Wright Medical, Wright Profemur Image Credit: | More Hip Replacements Lawsuit Stories Biomet Hip Lawsuit Filed Over Defective M2A Metal-on-Metal Implant December 26, 2024 Zimmer Biomet Lawsuit Filed Over RibFix Blu Implant Fracture September 25, 2024 Zimmer Biomet CPT Hip System Linked to Increased Risk of Thigh Bone Fractures, FDA Warns September 18, 2024 0 Comments PhoneThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Breast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (Posted: yesterday) Breast mesh implants promoted as internal bras are now under scrutiny, following studies and FDA warnings linking the devices to infections, implant loss, and surgical failure. Lawsuits are being investigated for women who suffered complications after reconstruction or augmentation procedures involving products like GalaFLEX, Phasix, Strattice, and AlloDerm. MORE ABOUT: BREAST MESH LAWSUITFDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023) Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: 2 days ago) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025) Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue (Posted: 3 days ago) Plaintiffs involved in GLP-1 vision loss lawsuits are calling for the litigation to be consolidated in New Jersey federal court, and not be bundled with existing stomach paralysis litigation. MORE ABOUT: OZEMPIC LAWSUITOzempic, Wegovy Kidney Side Effects Highlighted in New Study (10/10/2025)Reports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s (10/03/2025)Study Raises New Questions Over Ozempic Hair Loss Risks (09/26/2025)
Zimmer Biomet CPT Hip System Linked to Increased Risk of Thigh Bone Fractures, FDA Warns September 18, 2024
Breast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (Posted: yesterday) Breast mesh implants promoted as internal bras are now under scrutiny, following studies and FDA warnings linking the devices to infections, implant loss, and surgical failure. Lawsuits are being investigated for women who suffered complications after reconstruction or augmentation procedures involving products like GalaFLEX, Phasix, Strattice, and AlloDerm. MORE ABOUT: BREAST MESH LAWSUITFDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023)
Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: 2 days ago) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)
Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue (Posted: 3 days ago) Plaintiffs involved in GLP-1 vision loss lawsuits are calling for the litigation to be consolidated in New Jersey federal court, and not be bundled with existing stomach paralysis litigation. MORE ABOUT: OZEMPIC LAWSUITOzempic, Wegovy Kidney Side Effects Highlighted in New Study (10/10/2025)Reports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s (10/03/2025)Study Raises New Questions Over Ozempic Hair Loss Risks (09/26/2025)